We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

N-Nitroso Hydroxyzine EP Impurity A

Chemical Structure
Specifications
Product name
N-Nitroso Hydroxyzine EP Impurity A
SRC CAT No
SRC-N014051
CAS No
2005-04-1
Mol.F.
C17H18ClN3O
Mol.Wt.
315.80 g/mol
Related CAS No.
NA
Inv Status
IN STOCK
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
1-((4-chlorophenyl)(phenyl)methyl)-4-nitrosopiperazine

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Hydroxyzine is used to help control anxiety and tension caused by nervous and emotional conditions. It can also be used to help control anxiety and produce sleep before surgery. This medicine is also used to relieve symptoms of allergic conditions (eg, chronic urticaria and atopic and contact dermatoses). N-Nitroso Hydroxyzine Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso Hydroxyzine or N-Nitroso Hydroxyzine EP Impurity A cas NO:2005-04-1 chemically represented as 1-((4-chlorophenyl)(phenyl)methyl)-4-nitrosopiperazine. Synchemia is the leading manufacturing and exporter of N-Nitroso Hydroxyzine .We supply N-Nitroso Hydroxyzine with detailed characterization data compliance with regulatory guidelines.